First identified in 1989, eosinophilia-myalgia syndrome is a rare condition that produces inflammation in the muscles, lungs, and skin. Patients with this syndrome also have elevated levels of ...

A better understanding of inflammation and lung immunity over the past two decades has led to new, innovative treatments for asthma, including biologic therapies. This is especially true for a subtype ...

A team of researchers at University of Michigan and Boston University are tackling neutrophilic asthma, successfully developing one of the first mouse models of the condition.

This is especially true for a subtype known as eosinophilic asthma -- asthma that's related to the recruitment and overactivation of white blood cells in the lungs called eosinophils. However ...

This investigational trial will evaluate the effects of three dose levels of oral dexpramipexole for 12 weeks on peripheral blood eosinophil count, lung function, and asthma control. Additionally ...